Acelyrin Adopts Poison Pill
With Concentra Biosciences expanding its stock influence in Pliant Therapeutics and Acelyrin, the two biotechs have shored up ...
Pliant follows in the footsteps of Acelyrin, which also enacted a stockholder rights program on Thursday to protect ...
Acelyrin and Pliant Therapeutics, both of which are viewed as takeover targets for Kevin Tang’s Concentra Biosciences, each adopted a “poison pill” on Thursday morning.
One year ago, Cumulus Media initiated a “poison pill” defense to stave off the looming threat of a hostile takeover from billionaire Manoj Bhargava, who had been in acquisition mode with his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results